- CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis
[作者：May, F; Hagedorn, I; Pleines, I; Bender, M; Vogtle, T; Eble, J; Elvers, M; Nieswandt, B,期刊：Blood, 页码：3464-3472 , 文章类型： Article，,卷期：2009年114-16]
- Damage to the integrity of the vessel wall leads to exposure of the subendothelial extracellular matrix (ECM), triggering platelet activation and aggregation. This process is essential for primary hemostasis but it may a...
- Cerebrovascular reserve capacity is impaired in patients with sickle cell disease
[作者：Nur, E; Kim, YS; Truijen, J; van Beers, EJ; Davis, SCAT; Brandjes, DP; Biemond, BJ; van Lieshout, JJ,期刊：Blood, 页码：3473-3478 , 文章类型： Article，,卷期：2009年114-16]
- Sickle cell disease (SCD) is associated with a high incidence of ischemic stroke. SCD is characterized by hemolytic anemia, resulting in reduced nitric oxide-bioavailability, and by impaired cerebrovascular hemodynamics....
- Histone hyperacetylation within the beta-globin locus is context-dependent and precedes high-level gene expression
[作者：Fromm, G; de Vries, C; Byron, R; Fields, J; Fiering, S; Groudine, M; Bender, MA; Palis, J; Bulger, M,期刊：Blood, 页码：3479-3488 , 文章类型： Article，,卷期：2009年114-16]
- Active gene promoters are associated with covalent histone modifications, such as hyperacetylation, which can modulate chromatin structure and stabilize binding of transcription factors that recognize these modifications...
- Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor
[作者：Riddell, AF; Gomez, K; Millar, CM; Mellars, G; Gill, S; Brown, SA; Sutherland, M; Laffan, MA; McKinnon, TAJ,期刊：Blood, 页码：3489-3496 , 文章类型： Article，,卷期：2009年114-16]
- Investigation of 3 families with bleeding symptoms demonstrated a defect in the collagen-binding activity of von Willebrand factor (VWF) in association with a normal VWF multimeric pattern. Genetic analysis showed affect...
- Protecting against Aspergillus infection in CGD Response
[作者：Hakkim, A; Hurwitz, R; Bianchi, M; Brinkmann, V; Siler, U; Seger, RA; Zychlinsky, A; Reichenbach, J,期刊：Blood, 页码：3498-3498 , 文章类型： Letter，,卷期：2009年114-16]
-
- Chronic myeloid leukemia with p190(BCR-ABL): prevalence, morphology, tyrosine kinase inhibitor response, and kinase domain mutation analysis
[作者：Pardanani, A; Tefferi, A; Litzow, MR; Zent, C; Hogan, WJ; McClure, RF; Viswanatha, D,期刊：Blood, 页码：3502-3503 , 文章类型： Letter，,卷期：2009年114-16]
-
- Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells (vol 112, pg 5180, 2008)
[作者：Lapalombella, R; Yu, B; Triantafillou, G; Liu, Q; Butchar, JP; Lozanski, G; Ramanunni, A; Smith, LL; Blum, W; Andritsos, L; Wang, DS; Lehman, A; Chen, CS; Johnson, AJ; Marcucci, G; Lee, RJ; Lee, LJ; Tridandapani, S; Muthusamy, N; Byrd, JC,期刊：Blood, 页码：3506-3506 , 文章类型： Correction，,卷期：2009年114-16]
-
|